Catherine C. Smith

Catherine C. Smith

Hematology Oncology

400 Parnassus Ave.
Fourth Floor
San Francisco, CA 94143

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 6 publications

A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine.

A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine.

Journal: Science translational medicine

Published: May 07, 2025

Vaccination perspectives: the Qdenga® dilemma.

Vaccination perspectives: the Qdenga® dilemma.

Journal: Journal of travel medicine

Published: November 09, 2024

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

Journal: Lancet (London, England)

Published: October 30, 2020

Ebola virus antibody decay-stimulation in a high proportion of survivors.

Ebola virus antibody decay-stimulation in a high proportion of survivors.

Journal: Nature

Published: November 19, 2019

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone.

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone.

Journal: Transfusion

Published: September 05, 2017

Plasmodium knowlesi: clinical presentation and laboratory diagnosis of the first human case in a Scottish traveler.

Plasmodium knowlesi: clinical presentation and laboratory diagnosis of the first human case in a Scottish traveler.

Journal: Journal of travel medicine

Published: October 30, 2013

Showing 1-6 of 6

Last Updated: 09/26/2026